SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027950
Filing Date
2016-11-07
Accepted
2016-11-07 16:16:11
Documents
44
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20160930.htm 10-Q 1322052
2 EX-31.1 kura-ex311_11.htm EX-31.1 17192
3 EX-31.2 kura-ex312_8.htm EX-31.2 16956
4 EX-32.1 kura-ex321_9.htm EX-32.1 8977
  Complete submission text file 0001564590-16-027950.txt   4024060

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kura-20160930.xml EX-101.INS 796610
6 XBRL TAXONOMY EXTENSION SCHEMA kura-20160930.xsd EX-101.SCH 32094
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20160930_cal.xml EX-101.CAL 40803
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20160930_def.xml EX-101.DEF 67604
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20160930_lab.xml EX-101.LAB 227281
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20160930_pre.xml EX-101.PRE 157775
Mailing Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037
Business Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 161978308
SIC: 2834 Pharmaceutical Preparations